In addition, despite the in-silico validation demonstrated a clear shift in the expression of RUNX1 and TIMP1 between UC and CD in comparison to the normal tissue, due to our limited sample size and medical information, it hindered the comparison of data between UC and CD within our IBD samples and thus could be an interesting avenue to explore in the future. This evidence concerns the gene RUNX1 and inflammatory bowel disease.